RM-1929

· Rakuten Medical, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RM-1929, covering 2020-02-26 to 2020-02-26. Get the full timeline:

Most recent: Clinical Trial Update: Study of RM-1929 and Photoimmunotherapy in Patients With Recurrent Head and Neck Cancer [Phase 1, Phase 2]